Business Context and Reporting Period
Company: American Shared Hospital Services (ASHS)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2007
Business Overview: ASHS provides Gamma Knife radiosurgery units to medical centers. As of March 31, 2007, the company operated 21 Gamma Knife units across the United States. The company also holds investments in Still River Systems, Inc. (proton beam therapy) and is developing IMRT and operating room programs.
Key Financial Metrics
| Metric | Q1 2007 | Q1 2006 |
|---|---|---|
| Medical Services Revenue | $4,749,000 | $5,045,000 |
| Gross Margin | $2,230,000 (47.0%) | $2,423,000 (48.0%) |
| Operating Income | $602,000 | $946,000 |
| Net Income | $225,000 | $436,000 |
| Earnings Per Share (Diluted) | $0.04 | $0.09 |
| Net Cash from Operating Activities | $1,948,000 | $2,233,000 |
| Cash and Cash Equivalents (End of Period) | $3,221,000 | $1,166,000 |
| Total Assets | $50,651,000 | $50,905,000 (Dec 31, 2006) |
| Total Debt (Current + Long-Term) | $17,161,000 | N/A |
| Working Capital | ($1,107,000) | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased by $296,000 (5.9%) compared to Q1 2006. This was driven by a 62-procedure decrease in volume (607 vs. 669), attributed to a 5-week outage at one site for a cobalt reload, staffing issues at another site, and lower volume at other locations.
- Profitability Compression: Net income fell by $211,000 (48.4%). While costs of revenue decreased slightly ($103,000), selling and administrative expenses increased by $247,000, primarily due to payroll, consulting, and business development costs related to the proton beam business.
- Interest Expense: Interest expense decreased by $96,000 due to the completion of debt service on three term loans and lower balances on mature Gamma Knife units, partially offset by increased borrowing on the line of credit.
- Liquidity Position: Cash and cash equivalents decreased by $731,000 from the beginning of the period. This reduction was due to net investments in securities ($741,000), capital expenditures ($1,209,000), and debt repayments, partially offset by operating cash flow and new long-term debt financing ($2,110,000).
Guidance, Outlook, and Risks
- Contract Terminations: One Gamma Knife contract is scheduled to terminate in fall 2007, and another in early 2008. The company has a contract for IGRT services expected to begin in late 2007.
- Capital Commitments: The company has total remaining commitments of approximately $35,000,000 for the purchase of two Clinatron 250 systems and four Gamma Knife Perfexion units. Management believes it can finance these as needed.
- Debt Obligations: Scheduled interest and principal payments for the next 12 months are approximately $5,732,000, with capital lease payments of $1,355,000. Management asserts cash flow is adequate to meet these obligations.
- Dividends: The Board declared a quarterly dividend of $0.0475 per share on March 14, 2007, payable April 16, 2007.
- Risks: Risks include the development stage of the Still River investment, the Gamma Knife business risks, and the potential impact of contract terminations. No material legal proceedings were reported.
Investor Verification Checklist
- Revenue Volatility: Verify the impact of the cobalt reload outage and staffing issues on future quarterly volumes.
- Expense Growth: Monitor the trajectory of selling and administrative expenses related to the proton beam business development.
- Debt Service Coverage: Confirm the company's ability to service $7+ million in debt obligations over the next 12 months given the negative working capital position.
- Capital Expenditures: Track the funding status of the $35 million in equipment purchase commitments (Clinatron and Perfexion units).
- Contract Renewals: Assess the likelihood of renewing the two Gamma Knife contracts terminating in late 2007 and early 2008.